Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2013 Q1
25 of 25 quarters
Total Value
$2.0K
Total Shares
376
Net Share Change
+376
Activity
1 buying
Investor
Value
Shares
Weight
Change
Gardner Russo & Quinn
$2.0K
376
0.0%
NEW
Gardner Russo & Quinn
$2.0K
376 shares
NEW
HALO — Halozyme Therapeutics Inc - FilingSpy